Characteristics of study groups

VariableAdherent
(n = 1,072)
Non-adherent
(n = 79)
p-value
Female gender, n (%)461 (43.0)32 (40.5)0.665
Age, years (SD)63.7 (11.0)56.9 (12.8)< 0.001
European ethnicitya, n (%)927 (95.8)58 (82.9)< 0.001
Body mass index, kg/m2 (SD)29.7 (5.3)29.1 (5.0)0.315
Time since diagnosis of hypertension, years (SD)15.5 (11.4)11.4 (9.0)0.002
Smoking habits, n (%)
Never-smokers456 (42.5)32 (40.5)0.724
Previous smokers500 (46.7)31 (39.2)0.012
Smokers116 (10.8)16 (20.3)0.011
BPs and heart rate
Office systolic BP, mmHg (SD)143.2 (18.6)150.4 (22.0)0.001
Office diastolic BP, mmHg (SD) 82.0 (11.3)91.4 (14.8)< 0.001
Office heart rate, beats/min (SD)68.4 (12.6)70.4 (11.7)0.168
Ambulatory daytime systolic BP, mmHg (SD)136.4 (14.6)142.9 (16.4)< 0.001
Ambulatory daytime diastolic BP, mmHg (SD)79.6 (9.5)86.6 (12.4)< 0.001
Ambulatory daytime heart rate, beats/min (SD)70.4 (10.5)74.7 (10.9)< 0.001
Uncontrolled hypertensionb, n (%)553 (52.5)52 (68.4)0.007
Orthostatic hypotension, n (%)52 (4.9)4 (5.1)0.79
Biochemical and urine analyses (SD)
Serum total cholesterol, mmol/L4.9 (1.2)4.7 (0.9)0.037
Serum HDL, mmol/L1.5 (0.4)1.4 (0.5)0.501
Serum LDL, mmol/L3.1 (1.1)3.0 (0.9)0.318
Serum triglycerides, mmol/L1.8 (1.1)1.6 (1.0)0.071
Serum creatinine, µmol/L81.0 (23.7)77.5 (25.4)0.236
eGFR, mL/min/1.73 m280.4 (17.6)87.5 (19.0)< 0.001
Urine A/C ratio, mg/mmol6.6 (29.3)8.3 (37.9)0.644
HbA1c, mmol/mol40.3 (9.1)39.4 (11.3)0.432

Results are reported as n (%) or mean (SD), p-value denotes differences between the adherent and the non-adherent group. SD: standard deviation; BP: blood pressure; HDL: high-density lipoprotein; LDL: low-density lipoprotein; eGFR: estimated glomerular filtration rate; A/C: albumin/creatinine; HbA1c: hemoglobin A1c. a For the variable European ethnicity, there were in total n = 113 patients with missing data; b for the variable uncontrolled hypertension, n = 22 patients had missing data